Table 1 Summary of the 14 included studies
From: The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
Study | Origin of population | Study design | Disease | N | Stage | Method | Survival analysis | Hazard ratios | Follow-up Months |
|---|---|---|---|---|---|---|---|---|---|
Divya Sahu 2016 | China Taiwan | R | NB | 493 | IV/I-III | qRT-PCR | OS/EFS | HR/KM | 200 |
Zhang H 2016 | China | R | HCC | 122 | I-II/III-IV | qRT-PCR | NA | NA | NA |
Zhang M 2016 | China | R | HCC | 82 | A/B-C | qRT-PCR | OS | K-M | 60 |
Cui 2017 | China | R | NSCLC | 68 | I/II–III | qRT-PCR | OS | KM | 60 |
Hu 2017 | China | R | GC | 50 | NA | qRT-PCR | OS | KM | 60 |
Jiang2017 | China | R | OS | 25 | I-II/III-IV | qRT-PCR | NA | NA | NA |
Tang 2017 | China | R | LC | 43 | I-II/III-IV | qRT-PCR | NA | NA | NA |
Tian 2018 | China | R | CC | 82 | I-II/III-IV | qRT-PCR | OS/PFS | K-M | 120 |
Wang Q 2017 | China | R | Glioma | 78 | NA | qRT-PCR | OS | NA | 60 |
Wang JD 2018 | China | R | OS | 45 | NA | qRT-PCR | OS | KM | 60 |
Wang Sie 2017 | China | R | EOC | 67 | I-II/III-IV | qRT-PCR | OS | KM | 60 |
Zhang HY 2017 | China | R | SCC | 62 | I-II/III | qRT-PCR | NA | KM | NA |
Zhang YJ 2017 | China | R | ESCC | 72 | I- II/III | qRT-PCR | OS | KM | 60 |
Zhu 2017 | China | R | CRC | 108 | I-II/III-IV | qRT-PCR | OS/PFS | HR/KM | 60 |